The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, December 01, 2021
Merck and Ridgeback Biotherapeutics provided the following statement at the conclusion of the FDA Antimicrobial Drugs Advisory Committee (AMDAC) ...
read more
Wednesday, December 01, 2021
Merck announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a supplemental Biologics License Application (sBLA) for ...
read more
Monday, November 29, 2021
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and the European Medicines...
read more
Wednesday, November 24, 2021
Seqirus, a business of CSL Limited, announced that the FDA has granted supplemental approval of a multi-dose vial (MDV) presentation of AUDENZ™ (...
read more
Friday, November 19, 2021
New data from the AZD7442 COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials both showed robust efficacy from a one-time ...
read more
Friday, November 19, 2021
BioNTech SE announced that the FDA granted Fast Track Designation for BNT111, an investigational cancer immunotherapy for the potential treatment of ...
read more
Friday, November 19, 2021
Merck announced an update regarding the Phase 2 IMAGINE-DR clinical trial (MK-8507-13), which is evaluating the investigational combination of MK-8507...
read more
Thursday, November 18, 2021
Endo International plc announced that its Par Sterile Products business has begun shipping calcitonin salmon injection, USP, multi-dose vials (2 mL) ...
read more
Tuesday, November 16, 2021
The FDA approved Besremi (ropeginterferon alfa-2b-njft) injection to treat adults with polycythemia vera, a blood disease that causes the ...
read more
Wednesday, November 03, 2021
Legend Biotech Corp, a global, clinical-stage biotechnology company developing and manufacturing novel therapies, announced that the FDA has extended ...
read more
Monday, November 01, 2021
AstraZeneca has agreed to transfer its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/...
read more
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug ...
read more
Thursday, October 28, 2021
Oncopeptides AB, a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that ...
read more
Wednesday, October 27, 2021
Merck announced that the CDC’s Advisory Committee on Immunization Practices (ACIP) unanimously voted in favor of updates to pneumococcal vaccination ...
read more
Wednesday, October 20, 2021
FDA has approved ZIMHI (naloxone hydrochloride) injection as an additional option to treat opioid overdose. ZIMHI is administered using a single-dose,...
read more